StockData
Vericel Corp logo

Vericel Corp (VCEL) shareholders

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30325% above fair value
$57.88+0.40 (+0.70%)

Close on Nov 17, 2026Market cap $2.96BP/E 137.8Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
56M of 51M shares
Institutional holders
319
66 new, 22 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 44 sales
Net sold $13.00M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.7,570,28015.10%13G (passive) amendmentMar 31, 2025
State Street Corporation2,807,2425.60%13G (passive)Sep 30, 2025
Vanguard Capital Management2,603,1285.11%13G (passive)Mar 31, 2026
Soleus Capital, LLC
Joint filing with Soleus Capital Master Fund, L.P. (5.00%), Soleus Capital Group, LLC (5.00%) and 3 more
2,549,0795.00%13G (passive)Mar 31, 2026
Conestoga Capital Advisors LLC2,495,6195.23%13G (passive) amendmentDec 31, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of VCELValueChange% of portfolio
BlackRock, Inc.8,092,22615.80%$360.02M+326,8820.01%
State Street Corp3,293,9756.43%$146.58M+141,8450.00%
Congress Asset Management Co /Ma2,916,2955.70%$129.75M+1,409,3770.80%
Vanguard Capital Management LLC2,255,7284.41%$100.36M+24,9720.00%
Conestoga Capital Advisors, LLC2,083,8324.07%$92.71M−379,4802.02%
William Blair Investment Management, LLC1,992,8553.89%$88.66M+160,1460.27%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.1,639,9883.20%$72.96M−83,5840.07%
GW&K Investment Management, LLC1,550,4973.03%$68.98M−66,3580.54%
Soleus Capital Management, L.P.1,459,1522.85%$64.92M−1,089,9272.24%
Geode Capital Management, LLC1,341,2442.62%$59.68M+86,3820.00%
Geneva Capital Management LLC1,339,1232.62%$59.58M−307,6951.37%
Loomis Sayles & Co L P1,200,2392.34%$53.40M+224,7920.07%
Vanguard Portfolio Management LLC1,060,7532.07%$47.19M+69,1270.00%
Bank Of America Corp /De/1,016,1841.98%$45.21M−82,5870.00%
Dimensional Fund Advisors LP906,2001.77%$40.32M+61,4450.01%
Silvercrest Asset Management Group LLC896,6511.75%$39.89M−62,5560.26%
Royal Bank of Canada775,7621.51%$34.51M−106,4000.01%
Champlain Investment Partners, LLC755,8281.48%$33.63M−59,3450.86%
abrdn plc710,2381.39%$31.60M+26,1130.04%
Nomura Asset Management International Inc.664,3051.30%$29.56M+33,4260.04%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202631956M100.0%66 / 121100 / 227M6M
Q1 202627955M100.0%41 / 10597 / 3111M6M
Q4 202527354M100.0%55 / 10081 / 276M6M
Q3 202525053M100.0%29 / 8698 / 475M8M
Q2 202527356M100.0%35 / 13069 / 367M4M
Q1 202527754M100.0%32 / 11492 / 294M2M
Q4 202427852M100.0%44 / 10285 / 304M3M
Q3 202426851M100.0%32 / 10290 / 2312M4M
Q2 202426151M99.8%37 / 9592 / 294M5M
Q1 202425753M100.0%50 / 8387 / 206M7M
Q4 202322754M100.0%31 / 6096 / 154M2M
Q3 202321351M100.0%28 / 7777 / 175M3M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

265 funds held VCEL in Q2 2026, 51% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of VCELValue% of fundAs of
iShares Core S&P Small-Cap ETF3,077,1976.01%$136.90M0.12%Jun 30, 2026
Vanguard Total Stock Market Index Fund1,617,1883.16%$71.95M0.00%Jun 30, 2026
iShares Russell 2000 ETF1,337,6842.61%$59.51M0.07%Jun 30, 2026
Conestoga Small Cap Fund1,307,3552.55%$58.16M2.85%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1,194,3132.33%$53.13M0.49%Jun 30, 2026
Congress Small Cap Growth Fund1,090,0002.13%$50.10M2.49%Jul 31, 2026
Loomis Sayles Small Cap Growth Fund649,1651.27%$28.88M1.27%Jun 30, 2026
Vanguard Extended Market Index Fund583,7541.14%$25.97M0.03%Jun 30, 2026
Fidelity Small Cap Index Fund563,1991.10%$25.88M0.08%Jul 31, 2026
iShares Russell 2000 Growth ETF475,9140.93%$21.17M0.14%Jun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF469,5490.92%$20.89M0.12%Jun 30, 2026
William Blair Small Cap Growth Fund469,3540.92%$20.88M1.70%Jun 30, 2026
iShares S&P Small-Cap 600 Growth ETF459,0630.90%$20.42M0.25%Jun 30, 2026
Nomura Small Cap Growth Fund406,5490.79%$18.09M1.54%Jun 30, 2026
Brown Capital Management Small Company Fund373,0150.73%$16.60M5.17%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Dominick ColangeloPresident and CEO, Director321,2700.63%Feb 26, 2026
Joseph Anthony Mara JrChief Financial Officer16,1860.03%Nov 12, 2026
Jonathan SiegalPrincipal Accounting Officer1,2590.00%Nov 6, 2026
Sean C. FlynnChief Legal Officer1,9900.00%Nov 6, 2026
Michael HalpinChief Operating Officer32,7530.06%Aug 5, 2026
Jonathan Mark HopperChief Medical Officer75,7530.15%Jun 30, 2026
Karen MahoneyChief Human Resources Officer2,6250.01%Dec 12, 2025
Robert L. Zerbe MdDirector32,9950.06%Nov 12, 2026
Kevin F. McLaughlinDirector18,3000.04%Nov 12, 2026
Paul K. WottonDirector26,3020.05%May 13, 2026
Heidi HagenDirector35,0500.07%May 1, 2026
Lisa WrightDirector15,8510.03%May 1, 2026
Alan L. RubinoDirector64,2340.13%May 1, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 11, 2026Sale(10b5-1 plan)−8$59.75$47816,186
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 11, 2026Option exercise+8$43.63$34916,194
Kevin F. McLaughlin
Director
Nov 10, 2026Sale(10b5-1 plan)−7,000$58.96$412.72K18,300
Kevin F. McLaughlin
Director
Nov 10, 2026Option exercise+7,000$13.05$91.35K25,300
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 9, 2026Sale(10b5-1 plan)−25,000$58.26$1.46M16,186
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 9, 2026Option exercise+25,000$43.63$1.09M41,186
Robert L. Zerbe Md
Director
Nov 9, 2026Sale(10b5-1 plan)−2,000$57.88$115.76K32,995
Robert L. Zerbe Md
Director
Nov 9, 2026Option exercise+2,000$13.05$26.10K34,995
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 6, 2026Sale(10b5-1 plan)−14,573$53.43$778.64K16,186
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 6, 2026Option exercise+14,573$29.82$434.57K30,759
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 6, 2026Sale(10b5-1 plan)−14,068$53.41$751.37K16,186
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 6, 2026Option exercise+14,068$34.90$490.97K30,254
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 5, 2026Sale(10b5-1 plan)−10,427$53.73$560.24K16,186
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 5, 2026Option exercise+10,427$29.82$310.93K26,613
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 5, 2026Sale(10b5-1 plan)−10,932$53.40$583.77K16,186
Joseph Anthony Mara Jr
Chief Financial Officer
Nov 5, 2026Option exercise+10,932$34.90$381.53K27,118
Sean C. Flynn
Chief Legal Officer
Nov 5, 2026Sale(10b5-1 plan)−15,000$51.92$778.80K1,990
Sean C. Flynn
Chief Legal Officer
Nov 5, 2026Option exercise+15,000$16.25$243.75K16,990
Jonathan Siegal
Principal Accounting Officer
Nov 5, 2026Sale(10b5-1 plan)−1,500$52.90$79.35K1,259
Jonathan Siegal
Principal Accounting Officer
Nov 5, 2026Option exercise+1,500$34.90$52.35K2,759
Robert L. Zerbe Md
Director
Nov 5, 2026Sale(10b5-1 plan)−2,500$51.67$129.18K32,995
Robert L. Zerbe Md
Director
Nov 5, 2026Option exercise+2,500$13.05$32.63K35,495
Robert L. Zerbe Md
Director
Nov 5, 2026Sale(10b5-1 plan)−500$55.00$27.50K32,995
Robert L. Zerbe Md
Director
Nov 5, 2026Option exercise+500$13.05$6.53K33,495
Robert L. Zerbe Md
Director
Nov 4, 2026Sale(10b5-1 plan)−2,500$45.40$113.50K32,995
Robert L. Zerbe Md
Director
Nov 4, 2026Option exercise+2,500$13.05$32.63K35,495
Kevin F. McLaughlin
Director
Aug 12, 2026Sale(10b5-1 plan)−7,000$44.53$311.71K18,300
Kevin F. McLaughlin
Director
Aug 12, 2026Option exercise+7,000$13.05$91.35K25,300
Michael Halpin
Chief Operating Officer
Aug 3, 2026Sale(10b5-1 plan)−10,000$46.84$468.40K16,394
Michael Halpin
Chief Operating Officer
Aug 3, 2026Option exercise+10,000$16.66$166.60K26,394
Jonathan Siegal
Principal Accounting Officer
Jul 30, 2026Sale(10b5-1 plan)−500$48.90$24.45K1,078
Jonathan Siegal
Principal Accounting Officer
Jul 30, 2026Option exercise+1,500$34.90$52.35K2,578
Jonathan Siegal
Principal Accounting Officer
Jul 30, 2026Sale(10b5-1 plan)−1,500$48.90$73.35K1,078
Jonathan Siegal
Principal Accounting Officer
Jul 30, 2026Option exercise+2,500$29.82$74.55K3,578
Jonathan Siegal
Principal Accounting Officer
Jul 30, 2026Sale(10b5-1 plan)−2,500$48.90$122.25K1,078
Jonathan Siegal
Principal Accounting Officer
Jul 30, 2026Option exercise+500$29.82$14.91K1,578
Jonathan Siegal
Principal Accounting Officer
Jun 26, 2026Sale(10b5-1 plan)−232$44.90$10.42K886
Jonathan Siegal
Principal Accounting Officer
Jun 26, 2026Option exercise+2,500$29.82$74.55K3,386
Jonathan Siegal
Principal Accounting Officer
Jun 26, 2026Sale(10b5-1 plan)−2,500$44.90$112.25K886
Jonathan Mark Hopper
Chief Medical Officer
Jun 26, 2026Sale(10b5-1 plan)−5,000$45.00$225.00K75,753
Jonathan Mark Hopper
Chief Medical Officer
Jun 26, 2026Option exercise+5,000$29.82$149.10K80,753
Jonathan Mark Hopper
Chief Medical Officer
Jun 26, 2026Sale(10b5-1 plan)−5,000$45.00$225.00K75,753
Jonathan Mark Hopper
Chief Medical Officer
Jun 26, 2026Option exercise+5,000$29.82$149.10K80,753
Joseph Anthony Mara Jr
Chief Financial Officer
Jun 26, 2026Sale(10b5-1 plan)−5,000$44.75$223.75K16,009
Sean C. Flynn
Chief Legal Officer
Jun 26, 2026Sale(10b5-1 plan)−15,000$45.64$684.60K1,647
Sean C. Flynn
Chief Legal Officer
Jun 26, 2026Option exercise+15,000$16.25$243.75K16,647
Michael Halpin
Chief Operating Officer
Jun 18, 2026Sale(10b5-1 plan)−10,000$40.24$402.40K16,248
Michael Halpin
Chief Operating Officer
Jun 18, 2026Option exercise+10,000$16.66$166.60K26,248
Sean C. Flynn
Chief Legal Officer
Jun 18, 2026Sale(10b5-1 plan)−15,000$40.21$603.15K1,647
Sean C. Flynn
Chief Legal Officer
Jun 18, 2026Option exercise+15,000$16.25$243.75K16,647
Jonathan Mark Hopper
Chief Medical Officer
Jun 2, 2026Sale(10b5-1 plan)−4,375$35.00$153.13K75,753
Jonathan Mark Hopper
Chief Medical Officer
Jun 2, 2026Option exercise+4,375$16.66$72.89K80,128
Kevin F. McLaughlin
Director
May 13, 2026Sale(10b5-1 plan)−3,500$32.82$114.87K18,300
Kevin F. McLaughlin
Director
May 13, 2026Option exercise+3,500$2.63$9.21K21,800
Kevin F. McLaughlin
Director
May 13, 2026Sale(10b5-1 plan)−3,500$32.83$114.91K18,300
Kevin F. McLaughlin
Director
May 13, 2026Option exercise+3,500$13.05$45.68K21,800
Paul K. Wotton
Director
May 11, 2026Sale−2,500$33.05$82.63K26,302
Paul K. Wotton
Director
May 11, 2026Sale−7,500$32.64$244.80K18,802
Jonathan Siegal
Principal Accounting Officer
May 7, 2026Sale(10b5-1 plan)−1,422$40.50$57.59K1,118
Joseph Anthony Mara Jr
Chief Financial Officer
May 7, 2026Sale(10b5-1 plan)−5,000$40.50$202.50K21,009

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
10.61%
5M shares short
Days to cover
9.8
At 1M shares a day
Change since last report
+2.4%
From 5M shares
Short volume, 20 days
48.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Vericel's stock actually held short. Settlement fails (shares not delivered on time) peaked at 783 shares on Sep 15, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Kevin F. McLaughlin
Director
Nov 10, 20267,000$408.73KNov 10, 2026Stock Option Exercise
Robert L. Zerbe Md
Director
Nov 9, 20262,000$115.75KNov 9, 2026Stock Option Exercise
Joseph Anthony Mara Jr
Officer
Nov 9, 202625,000$1.46MNov 9, 2026Stock Option Exercise
Joseph Anthony Mara Jr
Officer
Nov 6, 202628,641$1.53MNov 6, 2026Stock Option Exercise
Joseph Anthony Mara Jr
Officer
Nov 6, 202628,641$1.53MNov 6, 2026Stock Option Exercise
Joseph Anthony Mara Jr
Officer
Nov 5, 202621,359$1.14MNov 5, 2026Stock Option Exercise
Sean C. Flynn
Officer
Nov 5, 202615,000$778.86KNov 5, 2026Stock Option Exercise
Robert L. Zerbe Md
Director
Nov 5, 20263,000$156.68KNov 5, 2026Stock Option Exercise
Jonathan Siegal
Officer
Nov 5, 20261,500$79.35KNov 5, 2026Stock Option Exercise
Robert L. Zerbe Md
Director
Nov 4, 20262,500$113.50KNov 4, 2026Stock Option Exercise
Kevin F. McLaughlin
Director
Aug 12, 20267,000$308.77KAug 12, 2026Stock Option Exercise
Michael Halpin
Officer
Aug 3, 202610,000$459.80KAug 3, 2026Stock Option Exercise
Jonathan Siegal
Officer
Jul 30, 20264,500$220.05KJul 30, 2026Stock Option Exercise
Sean C. Flynn
Officer
Jun 26, 202615,000$684.66KJun 26, 2026Stock Option Exercise
Joseph Anthony Mara Jr
Officer
Jun 26, 20265,000$223.75KJun 26, 2026Restricted Stock Vesting

See a number that looks wrong?